Pfizer sees about $15 billion in 2021 sales from Covid-19 vaccine
The company said it expects total 2021 revenue of between $59.4 billion and $61.4 billion
A man walks past a sign outside Pfizer Headquarters in the Manhattan borough of New York City, New York, US, July 22, 2020. Photo:Reuters
Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German partner BioNTech.
The company said it expects total 2021 revenue of between $59.4 billion and $61.4 billion.
Keep updated, follow The Business Standard's Google news channel
